Structural basis of RNA cap modification by SARS-CoV-2.

Area of Science:

• Virology
• Structural Biology
• Biochemistry

Background:

• Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes COVID-19.
• SARS-CoV-2 utilizes non-structural protein 16 (nsp16) and nsp10 to methylate viral mRNA.
• This methylation mimics cellular mRNA, evading host innate immune defenses.

Purpose of the Study:

• To determine the high-resolution structure of the SARS-CoV-2 nsp16/nsp10 complex.
• To elucidate the mechanism of mRNA 5' end methylation by nsp16/nsp10.
• To identify potential novel targets for antiviral drug development.

Main Methods:

• X-ray crystallography of the ternary complex (nsp16, nsp10, RNA analogue, SAM).
• Structural analysis to observe conformational changes upon substrate binding.
• Identification of ligand-binding sites.

Main Results:

• High-resolution structure of the SARS-CoV-2 nsp16/nsp10 ternary complex.
• Detailed visualization of the 2'-O methylation of viral mRNA.
• Observation of large conformational changes indicating an induced fit mechanism.
• Discovery of a unique, distant ligand-binding site on SARS-CoV-2 nsp16/nsp10.

Conclusions:

• The nsp16/nsp10 complex employs an induced fit mechanism for mRNA cap methylation.
• The identified unique ligand-binding site presents a novel target for antiviral therapies against SARS-CoV-2.
• Understanding this mechanism is crucial for developing effective COVID-19 treatments.